首页> 外国专利> GASTRIC RETENTIVE ORAL DOSAGE FORM WITH RESTRICTED DRUG RELEASE IN THE LOWER GASTROINTESTINAL TRACT.

GASTRIC RETENTIVE ORAL DOSAGE FORM WITH RESTRICTED DRUG RELEASE IN THE LOWER GASTROINTESTINAL TRACT.

机译:胃肠道下部下限释药的胃保留性口服剂型。

摘要

Controlled release oral dosage forms are provided for the continuous, sustained administration of a pharmacologically active agent to the upper gastrointestinal tract of a patient in whom the fed mode has been induced. The majority of the agent is delivered, on an extended release basis, to the stomach, duodenum and upper regions of the small intestine, with drug delivery in the lower gastrointestinal tract and colon substantially restricted. The dosage form comprises a matrix of a biocompatible, hydrophilic, erodible polymer with an active agent incorporated therein, wherein the polymer is one that both swells in the presence of water and gradually erodes over a time period of hours, with swelling and erosion commencing upon contact with gastric fluid, and drug release rate primarily controlled by erosion rate.
机译:提供了控释口服剂型,以将药理活性剂连续,持续地施用给已诱导进食方式的患者的上胃肠道。在延长释放的基础上,大部分药剂被递送到小肠的胃,十二指肠和上部区域,而在下胃肠道和结肠中的药物递送被基本上限制。该剂型包含生物相容性,亲水性,易侵蚀的聚合物的基质,其中掺入了活性剂,其中该聚合物是在水的存在下都溶胀并且在数小时的时间内逐渐侵蚀,并且在开始时溶胀和腐蚀的一种聚合物。与胃液接触后,药物释放速率主要受糜烂速率控制。

著录项

  • 公开/公告号MXPA04003930A

    专利类型

  • 公开/公告日2004-10-29

    原文格式PDF

  • 申请/专利权人 DEPOMED INC.;

    申请/专利号MX2004PA03930

  • 发明设计人 BERNER BRET;

    申请日2002-10-25

  • 分类号A61K31/00;A61K31/65;A61K9/20;A61K9/22;

  • 国家 MX

  • 入库时间 2022-08-21 23:09:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号